Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays - Wikidata - wikimedia - TriplyDB

Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays

Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays

http://www.wikidata.org/entity/Q24645130

about

Results of the National External Quality Assessment for Toxoplasmosis Serological Testing in China Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results.Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies.Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women.Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling.Interpretation of the Elecsys Toxo IgG avidity results for very low and very high index: study on 741 sera with a determined date of toxoplasmosis.The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.

P2860

Q28548298-862AB0A5-DD52-411E-A436-78CEB3DA794F Q34701351-77E6261F-DA34-4A48-8DAE-E3E6BA15EBB4 Q35140064-1589ACA3-D372-4577-9EAA-28C0F7D98D53 Q36378655-D646159A-EE98-48B7-811A-89D154210975 Q36606703-42977AB2-D793-4EDD-A74E-E59804F52B60 Q36971075-01E9AB73-2688-414C-8D71-C3A12F6E2466 Q37124736-3658D517-7155-4502-8444-C3ABFC8B1265 Q37360196-8F258971-3A75-4C81-8B7F-04362830E8D8 Q37643530-30581967-6B2F-40C2-A67F-824F5A743419 Q40403135-71512623-CE42-470F-8638-C961C1528BA9 Q42233996-C476F42D-27B0-469A-A659-B41203AD2CB1

P2860

Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays

http://www.wikidata.org/entity/Q24645130

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Development of fully automated ...... us and Toxo IgG Avidity assays

@ast

Development of fully automated ...... us and Toxo IgG Avidity assays

@en

Development of fully automated ...... us and Toxo IgG Avidity assays

@nl

type

label

Development of fully automated ...... us and Toxo IgG Avidity assays

@ast

Development of fully automated ...... us and Toxo IgG Avidity assays

@en

Development of fully automated ...... us and Toxo IgG Avidity assays

@nl

prefLabel

Development of fully automated ...... us and Toxo IgG Avidity assays

@ast

Development of fully automated ...... us and Toxo IgG Avidity assays

@en

Development of fully automated ...... us and Toxo IgG Avidity assays

@nl

P1433

Q24645130-2E13D0BA-8CF8-4852-9692-83BF46C159D7

P1476

Q24645130-D2A91056-B0D8-433B-BB92-73CD09758130

P2093

Q24645130-128292FF-52D8-47C3-A513-1976546238EC

Q24645130-245228FB-0789-47E7-BD27-991B7BDE725D

Q24645130-251D6CF3-B553-4212-A5C2-7A50257AC270

Q24645130-276FA1F0-4E66-45EA-997A-BE43C5A1EC9F

Q24645130-3670D44C-CFE0-44D0-9495-9DB86C851CBA

Q24645130-376C2285-8BF6-4418-A701-497F29398C18

Q24645130-37A5327E-2308-4C09-8FFD-1DF0A272D108

Q24645130-39F88708-CC28-4D15-9402-FE5028D5A144

Q24645130-43A8ABEC-E668-4E34-94D0-F71256A84114

Q24645130-4E079D53-8E6F-4626-9871-68F34FAA1E21

P2860

Q24645130-0B2F9251-DCD9-455C-B337-C48E2FB9504A

Q24645130-0D30DB7E-DC24-4435-810E-A37687F0FDAE

Q24645130-15FD1CC3-4660-461F-8DD9-BED327F1C672

Q24645130-1C46D34D-537B-44E7-A4D2-BAB8D19B0FF5

Q24645130-214DD585-51A6-423B-BD87-AE459513C845

Q24645130-26C16AF7-D238-46F8-89EF-B7CC4FFE47AF

Q24645130-34AFBB38-A351-4977-BEC5-2F74C36CD326

Q24645130-3837595B-036A-4A1B-9CD3-461D739EC181

Q24645130-3AD02B91-3442-456F-BBEE-B79CDA51BF2A

Q24645130-3F504D1A-8F67-408C-8D59-FB2DF9E8C422

P304

Q24645130-11797033-09EB-41F6-9F8F-F9560F76F7A5

P31

Q24645130-AB77E97A-52EC-4E76-86A6-C211941E458F

P3181

Q24645130-1F3E5C4C-B28D-4DC8-9952-1BC6A6FE7BEC

P356

Q24645130-FCE41AF4-4B88-4A4B-B5DC-A53703A8B48F

P407

Q24645130-2E305C94-8980-49F3-A0B1-E1154E85D2C8

P433

Q24645130-7B350EA0-C9ED-46B2-8C77-C30B8C60929E

P478

Q24645130-89EE3573-B00C-45C5-BF34-559B2418F3BE

P577

Q24645130-1FC3E29F-C682-4838-871C-17240839CD22

P5875

Q24645130-2B43C0D7-E85D-40C3-9344-E94B37681CB9

P698

Q24645130-D4CD86AF-1EE2-41F0-BD3E-B07374BA1100

P921

Q24645130-17EE5A5A-94C1-4AD6-8404-22A46FD0A314

Q24645130-37587BC9-7DF1-4B99-8C2D-465D07E2C6AB

P932

Q24645130-4AA3FF64-C22D-4D3C-AD5C-3E183BBAC75D

P3181

P356

P1433

Journal of Clinical Microbiology

P1476

Development of fully automated ...... us and Toxo IgG Avidity assays

@en

P2093

Darwin D Smith

http://www.w3.org/2001/XMLSchema#string

Dominick Pucci

http://www.w3.org/2001/XMLSchema#string

Eva Sickinger

http://www.w3.org/2001/XMLSchema#string

Gerald Praast

http://www.w3.org/2001/XMLSchema#string

Gregory T Maine

http://www.w3.org/2001/XMLSchema#string

Hans Bertram Braun

http://www.w3.org/2001/XMLSchema#string

Heike M Christ

http://www.w3.org/2001/XMLSchema#string

Ingo Curdt

http://www.w3.org/2001/XMLSchema#string

Iris Herold

http://www.w3.org/2001/XMLSchema#string

Jan Schultess

http://www.w3.org/2001/XMLSchema#string

P2860

A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid

Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed

European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.

Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults

VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.

Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.

Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method

Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin g avidity to human cytomegalovirus.

Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus

Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody.

P304

603-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2894789

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JCM.01076-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23764234

http://www.w3.org/2001/XMLSchema#string

P698

19129411

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

2650902

http://www.w3.org/2001/XMLSchema#string